Logo
StreamLex Home
Logo
StreamLex Home
Laws
Laws
Recitals
Recitals
Contact
About UsNewsRecitalsTrackersNewsletterTerms of UsePrivacy NoticeLinkedIn
EHDS
  • Data & Privacy

    • Data Act
    • Data Governance Act
    • EHDS
    • ePrivacy Directive
    • GDPR
  • AI & Trust

    • Artificial Intelligence Act
    • Product Liability Directive
  • Cybersecurity

    • Cyber Resilience Act
    • Cybersecurity Act
    • DORA
    • NIS2
  • Digital Services & Media

    • Digital Markets Act
    • Digital Services Act
    • European Media Freedom Act
EHDS

EHDS Article 54. Prohibited secondary use

  • Health data users shall only process electronic health data for secondary use on the basis of and in accordance with the purposes contained in a data permit issued pursuant to Article 68, health data requests approved pursuant to Article 69 or, in situations referred to in Article 67(3), an access approval from the relevant authorised participant in HealthData@EU referred to in Article 75. In particular, seeking access to and processing electronic health data obtained via a data permit issued pursuant to Article 68 or a health data request approved pursuant to Article 69 for the following uses shall be prohibited:
    • (a)
      taking decisions detrimental to a natural person or a group of natural persons based on their electronic health data; in order to qualify as ‘decisions’ for the purposes of this point, they have to produce legal, social or economic effects or similarly significantly affect those natural persons;
    • (b)
      taking decisions in relation to a natural person or a group of natural persons in relation to job offers, offering less favourable terms in the provision of goods or services, including exclusion of such persons or groups from the benefit of an insurance or credit contract, the modification of their contributions and insurance premiums or conditions of loans, or taking any other decisions in relation to a natural person or a group of natural persons which result in discriminating against them on the basis of the health data obtained;
    • (c)
      carrying out advertising or marketing activities;
    • (d)
      developing products or services that may harm individuals, public health or society at large, such as illicit drugs, alcoholic beverages, tobacco and nicotine products, weaponry or products or services which are designed or modified in such a way that they create addiction, contravene public order or cause a risk for human health;
    • (e)
      carrying out activities in conflict with ethical provisions laid down in national law.

Relevant Recitals for this Article

© 2025 StreamLex

NewsletterAbout UsTerms of UsePrivacy NoticeManage cookies

© 2025 StreamLex